- Home
- PHAT vs TMP Comparison
PHAT vs TMP Comparison
Compare PHAT & TMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PHAT | TMP |
|---|---|---|
| Founded | 2018 | 1836 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 942.6M | 1.1B |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | PHAT | TMP |
|---|---|---|
| Price | $13.92 | $77.01 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | $17.33 | ★ $74.00 |
| AVG Volume (30 Days) | ★ 1.4M | 57.1K |
| Earning Date | 03-05-2026 | 01-28-2026 |
| Dividend Yield | N/A | ★ 3.41% |
| EPS Growth | N/A | ★ 27.02 |
| EPS | N/A | ★ 5.90 |
| Revenue | $147,190,000.00 | ★ $316,920,000.00 |
| Revenue This Year | $220.82 | $16.28 |
| Revenue Next Year | $82.87 | $1.90 |
| P/E Ratio | ★ N/A | $12.91 |
| Revenue Growth | ★ 460.30 | 10.67 |
| 52 Week Low | $2.21 | $54.16 |
| 52 Week High | $18.31 | $77.33 |
Technical Indicators
Market Signals| Indicator | PHAT | TMP |
|---|---|---|
| Relative Strength Index (RSI) | 40.75 | 62.04 |
| Support Level | $13.79 | $72.80 |
| Resistance Level | $16.12 | $75.34 |
| Average True Range (ATR) | 0.95 | 1.74 |
| MACD | -0.33 | 0.08 |
| Stochastic Oscillator | 5.72 | 84.30 |
Price Performance
Historical ComparisonAbout PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About TMP Tompkins Financial Corporation
Tompkins Financial Corp is a Financial Holding Company. It has three business segments, consisting of banking, insurance and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Insurance is comprised of property and casualty insurance services and employee benefit consulting. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates majority of its revenue from Banking segment.